Literature DB >> 10700426

Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

G I Mason1, J Hamburger, J B Matthews.   

Abstract

OBJECTIVE: To determine whether there was altered elaboration of non-collagenous extracellular matrix proteins or expression of TGFbeta isoforms and their receptors in salivary glands of patients with systemic sclerosis (SSc) and Raynaud's phenomenon (RP). Because of the possible role of mast cells in the early stages of SSc their presence was also investigated.
METHODS: Sections of normal labial salivary glands (n=10) and glands from patients with SSc (n = 13) and RP (n = 5) were stained immunohistochemically and using acid toluidine blue.
RESULTS: SSc glands contained more mast cells than control tissues (p<0.005) and similar numbers to those found in RP specimens. There were no differences in the pattern or amount of non-collagenous matrix proteins detected. Tenascin and elastin were predominantly found surrounding ducts whereas fibronectin had a more general distribution. TGFbeta isoforms and receptors were expressed by glandular epithelium, fibroblasts, vascular endothelium and inflammatory cells. Cell counts showed no differences in expression of TGFbeta1 or TGFbeta receptors between groups. However, the percentage of TGFbeta2 positive fibroblasts was significantly higher in SSc glands compared with controls (p<0.004). RP glands showed an intermediate level of expression. By contrast, a lower percentage of RP fibrolasts expressed TGFbeta3 compared with controls with SSc glands showing an intermediate level of expression.
CONCLUSIONS: These results show that (a) there are no changes in glandular expression of tenascin, elastin and fibronectin in SSc and RP and (b) both conditions are associated with an increased salivary gland mast cell population and changes in expression of TGFbeta2 and beta3 isoforms by glandular fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700426      PMCID: PMC1753093          DOI: 10.1136/ard.59.3.183

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

1.  A case of Sjögren's disease with scleroderma.

Authors:  A B HARRINGTON; H A DEWAR
Journal:  Br Med J       Date:  1951-06-09

2.  Distribution of mast cells in human dermis: development of a mapping technique.

Authors:  T Cowen; P Trigg; R A Eady
Journal:  Br J Dermatol       Date:  1979-06       Impact factor: 9.302

3.  Sjögren's syndrome in progressive systemic sclerosis (scleroderma).

Authors:  D Alarcón-Segovia; G Ibánez; J Hernández-Ortíz; F Velázquez-Forero; Y González-Jiménez
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

4.  Macrophage production of fibronectin, a chemoattractant for fibroblasts.

Authors:  Y Tsukamoto; W E Helsel; S M Wahl
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

5.  T6 antigen-positive cells in human labial salivary glands.

Authors:  J B Matthews; A J Potts; J Hamburger; D G Scott
Journal:  Arch Oral Biol       Date:  1985       Impact factor: 2.633

6.  The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts.

Authors:  A Fine; R H Goldstein
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

7.  Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.

Authors:  R B Buckingham; R K Prince; G P Rodnan
Journal:  J Lab Clin Med       Date:  1983-05

8.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

Authors:  R A Hawkins; H N Claman; R A Clark; J C Steigerwald
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

9.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Authors:  A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

10.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.

Authors:  A E Postlethwaite; J Keski-Oja; G Balian; A H Kang
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  7 in total

1.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Tenascin-C in chronic sclerosing sialadenitis.

Authors:  Apostolos Epivatianos; Fotis Iordanidis; Dimitrios Andreadis; Savas Iordanidis; Athanasios Poulopoulos; Anastasios Markopoulos
Journal:  Head Neck Pathol       Date:  2011-05-11

3.  Deficient Smad7 expression: a putative molecular defect in scleroderma.

Authors:  Chunming Dong; Shoukang Zhu; Tao Wang; Woohyun Yoon; Zhiru Li; Rene J Alvarez; Peter ten Dijke; Barbara White; Fredrick M Wigley; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions.

Authors:  Weili Zhang; Amanda L Chancey; Huei-Ping Tzeng; Zhenqing Zhou; Kory J Lavine; Feng Gao; Natarajan Sivasubramanian; Philip M Barger; Douglas L Mann
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

5.  Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesions.

Authors:  G I Mason; J Hamburger; S Bowman; J B Matthews
Journal:  Mol Pathol       Date:  2003-02

Review 6.  The role of type 1 interferon in systemic sclerosis.

Authors:  Minghua Wu; Shervin Assassi
Journal:  Front Immunol       Date:  2013-09-06       Impact factor: 7.561

Review 7.  Salivary Biomarkers in Systemic Sclerosis Disease.

Authors:  Zeineb Zian; Joaira Bakkach; Amina Barakat; Naima Ghailani Nourouti; Mohcine Bennani Mechita
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.